-
1.
公开(公告)号:US5656592A
公开(公告)日:1997-08-12
申请号:US128912
申请日:1993-09-29
申请人: Brian Seed , John C. Seed
发明人: Brian Seed , John C. Seed
CPC分类号: A61K38/2221
摘要: Disclosed is a method of reducing pain in a mammal involving administration of relaxin to the mammal.
摘要翻译: 公开了减少哺乳动物涉及向哺乳动物施用松弛素的疼痛的方法。
-
2.
公开(公告)号:US5861399A
公开(公告)日:1999-01-19
申请号:US680684
申请日:1996-07-17
申请人: Brian Seed , John C. Seed
发明人: Brian Seed , John C. Seed
IPC分类号: A61K31/505 , A61K31/506 , A61K31/60 , A61K31/785 , A61K31/495 , A61K31/40 , A61K31/44 , A61K31/50
CPC分类号: A61K31/505 , A61K31/506 , A61K31/60 , A61K31/785 , Y10S514/824
摘要: Disclosed are methods and compositions for reducing coronary artery stenosis, restoring blood flow to infarcted myocardium, improving myocardial perfusion, reducing heart attacks or other adverse cardiovascular events, or treating symptoms of inadequate myocardial function in a mammal involving administering to the mammal (a) a compound that includes eicosapentaeneoic acid or docosahexaeneoic acid and (b) a cholesterol-lowering therapeutic, combined with dietary restrictions (resulting in aggressive loading of marine lipids), whereby a serum LDL concentration of less than 75 mg/dl (and preferably less than 55 mg/dl) is achieved. One particular method involves administering to the mammal a combination that includes (a) a compound that includes an eicosapentaeneoic or docosahexaeneoic acid (for example, a marine lipid) and (b) a cholesterol synthesis or transfer inhibitor, and which may also optionally include aspirin and/or niacin. The methods and compositions of the invention may also further include a bile acid sequestrant and/or buspirone. Also disclosed are methods for treating heart disease that involve administration of buspirone.
-
3.
公开(公告)号:US07109206B2
公开(公告)日:2006-09-19
申请号:US09735024
申请日:2000-12-12
申请人: Brian Seed , John C. Seed
发明人: Brian Seed , John C. Seed
IPC分类号: A61K31/505 , A61K31/44 , A61K31/40 , A61K31/35 , A61K31/21
CPC分类号: A61K31/505 , A61K31/506 , A61K31/60 , A61K31/785 , Y10S514/824 , A61K2300/00
摘要: Disclosed are methods and compositions for reducing coronary artery stenosis, restoring blood flow to infarcted myocardium, improving myocardial perfusion, reducing heart attacks or other adverse cardiovascular events, or treating symptoms of inadequate myocardial function in a mammal involving administering to the mammal (a) a compound that includes eicosapentaeneoic acid or docosahexaeneoic acid and (b) a cholesterol-lowering therapeutic, combined with dietary restrictions (resulting in aggressive loading of marine lipids), whereby a serum LDL concentration of less than 75 mg/dl (and preferably less than 55 mg/dl) is achieved. One particular method involves administering to the mammal a combination that includes (a) a compound that includes an eicosapentaeneoic or docosahexaeneoic acid (for example, a marine lipid) and (b) a cholesterol synthesis or transfer inhibitor, and which may also optionally include aspirin and/or niacin. The methods and compositions of the invention may also further include a bile acid sequestrant and/or buspirone. Also disclosed are methods for treating heart disease that involve administration of buspirone.
-
4.
公开(公告)号:US06159993A
公开(公告)日:2000-12-12
申请号:US198874
申请日:1998-11-24
申请人: Brian Seed , John C. Seed
发明人: Brian Seed , John C. Seed
IPC分类号: A61K31/505 , A61K31/506 , A61K31/60 , A61K31/785 , A61K31/20 , A61K31/04
CPC分类号: A61K31/505 , A61K31/506 , A61K31/60 , A61K31/785 , Y10S514/824 , A61K2300/00
摘要: Disclosed are methods and compositions for reducing coronary artery stenosis, restoring blood flow to infarcted myocardium, improving myocardial perfusion, reducing heart attacks or other adverse cardiovascular events, or treating symptoms of inadequate myocardial function in a mammal involving administering to the mammal (a) a compound that includes eicosapentaeneoic acid or docosahexaeneoic acid and (b) a cholesterol-lowering therapeutic, combined with dietary restrictions (resulting in aggressive loading of marine lipids), whereby a serum LDL concentration of less than 75 mg/dl (and preferably less than 55 mg/dl) is achieved. One particular method involves administering to the mammal a combination that includes (a) a compound that includes an eicosapentaeneoic or docosahexaeneoic acid (for example, a marine lipid) and (b) a cholesterol synthesis or transfer inhibitor, and which may also optionally include aspirin and/or niacin. The methods and compositions of the invention may also further include a bile acid sequestrant and/or buspirone. Also disclosed are methods for treating heart disease that involve administration of buspirone.
-
公开(公告)号:US4895845A
公开(公告)日:1990-01-23
申请号:US907837
申请日:1986-09-15
申请人: John C. Seed
发明人: John C. Seed
IPC分类号: A61K31/475 , A61K45/06
CPC分类号: A61K45/06 , A61K31/475 , Y10S514/91
摘要: A method of assisting weight loss involving the combined administration of a rauwolfia alkaloid and at least one antidepressant, selected from the groups consisting of aminoazoles, phenoxyphenylpropylamines, and aminopropiophenones, in a daily regimen with the optional co-administration of one or more sympathomimetic anorexic agents. In a typical embodiment of this method, reserpine and trazodone are administered in a daily regimen with diethylpropion, fenfluramine or both diethylpropion and fenfluramine.
摘要翻译: 一种辅助减肥的方法,其涉及在每日方案中选择由氨基咔唑,苯氧基苯丙基胺和氨基苯丙酮组成的组中的至少一种抗癫痫药物组合施用,任选地共同施用一种或多种拟交感神经厌食症剂 。 在该方法的典型实施方案中,利血平和曲唑酮以每日方案与二乙基丙酸,芬氟拉明或二丙酸和芬氟拉明两者一起施用。
-
公开(公告)号:US20090238904A1
公开(公告)日:2009-09-24
申请号:US12474745
申请日:2009-05-29
申请人: John C. Seed
发明人: John C. Seed
IPC分类号: A61K36/68
CPC分类号: A61K36/68 , A23G9/32 , A23G9/42 , A23L29/37 , A23L33/21 , A23V2002/00 , A23V2250/502 , A23V2250/64 , A23V2250/242 , A23V2250/264 , A23V2200/332 , A23V2250/5074
摘要: Compositions, which include psyllium and polyethylene glycol in a weight ratio of psyllium to polyethylene glycol of from about 1:3 to about 2:1, a gum, and one or more additional ingredients selected from the group consisting of water, salt, sweeteners, flavoring agents, and preservatives are presented.
摘要翻译: 组合物,其包含车前子和聚乙二醇,其重量比为约1:3至约2:1的车前子与聚乙二醇,胶和一种或多种另外的选自水,盐,甜味剂, 调味剂和防腐剂。
-
公开(公告)号:US20090156561A1
公开(公告)日:2009-06-18
申请号:US12140785
申请日:2008-06-17
申请人: John C. Seed
发明人: John C. Seed
IPC分类号: A61K31/662 , A61K31/445 , A61K31/27 , A61P25/34
CPC分类号: A61K31/27 , A61K31/445 , A61K31/662
摘要: A method of causing a patient to reduce or cease tobacco use that involves the administration of a cholinesterase inhibitor.
摘要翻译: 使患者减少或停止涉及施用胆碱酯酶抑制剂的烟草使用的方法。
-
公开(公告)号:US20090110758A1
公开(公告)日:2009-04-30
申请号:US11924189
申请日:2007-10-25
申请人: John C. Seed , Denise Johnson
发明人: John C. Seed , Denise Johnson
CPC分类号: A61K36/68 , A23G9/32 , A23G9/42 , A23L29/37 , A23L33/21 , A23V2002/00 , A23V2250/502 , A23V2250/64 , A23V2250/242 , A23V2250/264 , A23V2200/332 , A23V2250/5074
摘要: Compositions, which include psyllium and polyethylene glycol in a weight ratio of psyllium to polyethylene glycol of from about 1:3 to about 2:1, a gum, and one or more additional ingredients selected from the group consisting of water, salt, sweeteners, flavoring agents, and preservatives are presented.
摘要翻译: 组合物,其包含车前子和聚乙二醇,其重量比为约1:3至约2:1的车前子与聚乙二醇,胶和一种或多种另外的选自水,盐,甜味剂, 调味剂和防腐剂。
-
-
-
-
-
-
-